PepGen Shares 2023 Q2 Newsletter

July 21, 2023

On July 17, 2023, PepGen shared clinical updates for their Duchenne muscular dystrophy and Myotonic dystrophy type 1 studies and more.

Please click here to view a PDF of their Q2 newsletter.

Experience the magic this summer!

How is the rare disease community accomplishing goals?

Tune in on February 29 to hear from our panel and moderators on how they are accomplishing goals and living life to the fullest!

Your gift helps Jett Foundation provide programming and opportunities, such as Camp Promise, to many families impacted by Duchenne muscular dystrophy each year.

Accessible Vehicle Fund Applications Open